Masahiro Hiraoka

Hypofractionated Stereotactic Radiotherapy (HypoFXSRT) for Stage I Non-small Cell Lung Cancer: Updated Results of 257 Patients in a Japanese Multi-institutional Study

Hiroshi Onishi, Hiroki Shirato, Yasushi Nagata et al. · Journal of Thoracic Oncology · 2007 · 969 citations · Full text

Radiation Therapy, Medicine, Japanese Multi-institutional Study +7

Stereotactic hypofractionated high‐dose irradiation for stage I nonsmall cell lung carcinoma

Hiroshi Onishi, Tsutomu Araki, Hiroki Shirato et al. · Cancer · 2004 · 902 citations · Full text

Correction: Corrigendum: Cancer cells that survive radiation therapy acquire HIF-1 activity and translocate toward tumour blood vessels

Hiroshi Harada, Masahiro Inoue, Satoshi Itasaka et al. · Nature Communications · 2013 · 676 citations · Full text

Tumor Biology, Radiation Medicine, Radiation Therapy +10

Clinical outcomes of a phase I/II study of 48 Gy of stereotactic body radiotherapy in 4 fractions for primary lung cancer using a stereotactic body frame

Yasushi Nagata, Kenji Takayama, Yukinori Matsuo et al. · International Journal of Radiation Oncology*Biology*Physics · 2005 · 673 citations

Stereotactic Body Frame, Radiation Therapy, Medicine +8

Thyroid Gland Tumor Diagnosis at US Elastography

Andrej Lyshchik, Tatsuya Higashi, Ryo Asato et al. · Radiology · 2005 · 631 citations